Top Research Papers on Schizophrenia
Explore our comprehensive list of top research papers on Schizophrenia. These papers provide groundbreaking insights and pioneering studies that delve deep into understanding this complex mental health condition. Stay updated with the latest findings from the field and enhance your knowledge on Schizophrenia.
Looking for research-backed answers?Try AI Search
Schizophrenia, characterised by psychotic symptoms and in many cases social and occupational decline, remains an aetiological and therapeutic challenge. Contrary to popular belief, the disorder is modestly more common in men than in women. Nor is the outcome uniformly poor. A division of symptoms into positive, negative, and disorganisation syndromes is supported by factor analysis. Catatonic symptoms are not specific to schizophrenia and so-called first rank symptoms are no longer considered diagnostically important. Cognitive impairment is now recognised as a further clinical feature of the ...
Neuroimaging Biomarkers in Schizophrenia
231 Citations 2021Nina V. Kraguljac, William M. McDonald, Alik S. Widge + 3 more
American Journal of Psychiatry
A range of mechanistically plausible neuroimaging biomarkers for disease risk, diagnosis, target engagement, and treatment response in schizophrenia are discussed, including dopamine hyperactivity, N-methyl-d-aspartate receptor hypofunction, hippocampalhyperactivity, immune dysregulation, dysconnectivity, and cortical gray matter volume loss.
Treatment-Resistant Schizophrenia
137 Citations 2021Christoph U. Correll, Oliver Howes
The Journal of Clinical Psychiatry
Earlier and broader use of clozapine in patients with TRS is an important measure to improve outcomes of patients with this most severe form of the illness, and studies indicate that response rates are higher when clozAPine is initiated earlier in the treatment course.
Glutamatergic dysfunction in Schizophrenia
111 Citations 2022Andreas O. Kruse, Juan Bustillo
Translational Psychiatry
The NMDA-R hypofunction model of schizophrenia started with the clinical observation of the precipitation of psychotic symptoms in patients with schizophrenia exposed to PCP or ketamine, and the genetic literature directly supports a non- specific etiological role for glutamatergic dysfunction.
Anomalies in language as a biomarker for schizophrenia
115 Citations 2020Janna N. de Boer, Sanne Brederoo, Alban Voppel + 1 more
Current Opinion in Psychiatry
Current advances in evaluating the use of language as a diagnostic or prognostic tool in schizophrenia are reviewed, suggesting an important role for language analyses in the diagnosis and prognosis of schizophrenia.
Neurobiology of Schizophrenia: A Comprehensive Review
122 Citations 2022Enkhmaa Luvsannyam, Molly S Jain, Maria Kezia Lourdes Pormento + 4 more
Cureus
Specific regions of gray and white matter changes are observed in patients with schizophrenia; gray matter changes being more significant after the onset of psychosis; these pathological changes may be implicated in the impairment of executive functioning, attention, and working memory.
Genomic findings in schizophrenia and their implications
133 Citations 2023Michael J. Owen, Sophie E. Legge, Elliott Rees + 2 more
Molecular Psychiatry
Substantive progress in biological understanding will require parallel advances in functional genomics and proteomics applied to the brain across developmental stages and for these efforts to succeed in identifying disease mechanisms and defining novel strata they will need to be combined with sufficiently granular phenotypic data.
The Role of Inflammation in the Treatment of Schizophrenia
135 Citations 2020Guillaume Fond, Christophe Lançon, Théo Korchia + 2 more
Frontiers in Psychiatry
Background: Inflammation plays a major role in the onset and maintenance of schizophrenia. The objective of the present work was to synthetize in a narrative review the recent findings in the field of inflammation in schizophrenia and their application in daily practice.
Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium
109 Citations 2022Constantinos Constantinides, Laura K. M. Han, Clara Alloza + 91 more
Molecular Psychiatry
This large-scale collaborative study suggests advanced structural brain ageing in SZ, and among SZ patients, brain-PAD was not associated with specific clinical characteristics (age of onset, duration of illness, symptom severity, or antipsychotic use and dose).
Efficacy and Safety of Lumateperone for Treatment of Schizophrenia
273 Citations 2020Christoph U. Correll, Robert E. Davis, Michal Weingart + 7 more
JAMA Psychiatry
This randomized clinical trial examines the efficacy and safety of lumateperone for the short-term treatment of adults with schizophrenia.
Genetics of schizophrenia in the South African Xhosa
116 Citations 2020Süleyman Gülsüner, Dan J. Stein, Ezra Susser + 25 more
Science
It is found that the genetic architecture of schizophrenia in Africans generally reflects that of Europeans but that the greater genetic variation in Africa provides more power to detect relationships of genes to phenotypes.
Vitamin D and schizophrenia: 20 years on
112 Citations 2021Xiaoying Cui, John J. McGrath, Thomas H.J. Burne + 1 more
Molecular Psychiatry
The hypothesis that vitamin D deficiency during early life may increase the risk of schizophrenia remains plausible and warrants ongoing research.
Primary and Secondary Negative Symptoms in Schizophrenia
110 Citations 2022Sergey Mosolov, Polina A. Yaltonskaya
Frontiers in Psychiatry
This review and position paper covers the historical and modern concepts of the paradigm of positive and negative symptoms in schizophrenia, as well as a detailed comparison of the assessment tools and psychometric tests used for the evaluation of negative symptoms.
The Economic Burden of Schizophrenia in the United States
161 Citations 2022Aditi Kadakia, Maryaline Catillon, Qi Fan + 5 more
The Journal of Clinical Psychiatry
The estimated burden of schizophrenia in the US doubled between 2013 and 2019 and was $343.2 billion in 2019, highlighting the importance of effective strategies and treatment options to improve the management of this difficult-to-treat patient population.
EEG microstates are a candidate endophenotype for schizophrenia
226 Citations 2020Janir Nuno da Cruz, Ophélie Favrod, Maya Roinishvili + 5 more
Nature Communications
Patients and their siblings show similar microstate abnormalities compared to healthy controls, suggesting that the dynamics of microstate classes C and D are a candidate endophenotype for schizophrenia.
EEG microstate features for schizophrenia classification
101 Citations 2021Kyungwon Kim, Nguyen Thanh Duc, Minsung Choi + 1 more
PLoS ONE
Electroencephalography (EEG) microstate analysis is a method wherein spontaneous EEG activity is segmented at sub-second levels to analyze quasi-stable states. In particular, four archetype microstates and their features are known to reflect changes in brain state in neuropsychiatric diseases. However, previous studies have only reported differences in each microstate feature and have not determined whether microstate features are suitable for schizophrenia classification. Therefore, it is necessary to validate microstate features for schizophrenia classification. Nineteen microstate features,...
Maintenance treatment with antipsychotic drugs for schizophrenia
169 Citations 2020Anna Ceraso, Jingxia Lin, Johannes Schneider‐Thoma + 7 more
Cochrane Database of Systematic Reviews
The efficacy of antipsychotic drugs for maintenance treatment in schizophrenia was clear and hospitalisation was reduced and underpowered data revealed no evidence of a difference between groups for the outcome 'Death due to suicide'.
Compression of Cerebellar Functional Gradients in Schizophrenia
106 Citations 2020Debo Dong, Cheng Luo, Xavier Guell + 5 more
Schizophrenia Bulletin
The abnormalities in the distribution of sensorimotor-supramodal hierarchical processing topography in the cerebellum and cerebellar-cerebral circuits in schizophrenia are investigated using a novel gradient-based resting-state functional connectivity (FC) analysis.
The role of the gut microbiome in the development of schizophrenia
104 Citations 2020John R. Kelly, Chiara Minuto, John F. Cryan + 2 more
Schizophrenia Research
Unravelling MGB axis signalling in the context of an evolving dimensional framework in schizophrenia may provide a more complete understanding of the neurobiological architecture of this complex condition and offers the possibility of translational interventions.
Schizophrenia and Sex Hormones: What Is the Link?
111 Citations 2020Noa A. Brzezinski‐Sinai, Amnon Brzezinski
Frontiers in Psychiatry
The current knowledge on the link between blood levels of sex-hormones in women during the various stages of the female reproductive life and the course of schizophrenia is presented and the clinical approach to women with schizophrenia at these different stages is attempted.